More on UTHR
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $490.24 |
|
|||
| Open | $484.33 | ||||
| 52 Wk High | $164.04 | ||||
| 52 Wk Low | $97.52 | ||||
| Day High | $494.09 | ||||
| Day Low | $484.33 | ||||
| P/E | 89.14 | ||||
| EPS | $5.47 | ||||
| Volume | 327,025 | ||||
- FDA accepts United Therapeutics' drug application for IPF treatment
- FDA accepts United Therapeutics' sNDA for Tyvaso to treat IPF
- Form 4 UNITED THERAPEUTICS Corp For: Aug 27 Filed by: ROTHBLATT MARTINE A
- United Therapeutics presents drug trial data at two European congresses
- United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society International Congress 2026
- Form 4 UNITED THERAPEUTICS Corp For: Aug 26 Filed by: ROTHBLATT MARTINE A
- Form 4 UNITED THERAPEUTICS Corp For: Aug 25 Filed by: ROTHBLATT MARTINE A
- Form 4 UNITED THERAPEUTICS Corp For: Aug 24 Filed by: ROTHBLATT MARTINE A
- Form 4 UNITED THERAPEUTICS Corp For: Aug 21 Filed by: ROTHBLATT MARTINE A
- FDA accepts United Therapeutics NDA for ralinepag PAH treatment
Entities mentioned with UTHR
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Maynard Um | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Cowen & Co | View Related Stories »
- Show More...
